Heart Failure Association (HFA) of the ESC

Thank you for your contributions, we received more abstracts than ever!  More than 100 scientific sessions on hot topics in heart failure will be presented by global experts and supply a rich source of news and educationa opportunities.

Consult the Final Programme, and read more about what to expect at HF 2013. See you in Lisbon from 25-28 May!

The ESC Heart Failure Congress 2013 promises more science than ever this year, with a record number of abstracts submitted. The congress takes place 25-28 May at the Centro de Congressos de Lisboa in Lisbon, Portugal. More than 1,500 scientific abstracts from around the globe will be presented. Another highlight will be the late breaking clinical trials sessions with state of the art, unpublished, large multicentre trials in the field of heart failure.
Read more about what to expect at the congress.

ESC Journals article - editor's choice
Gheorghiade et al.
In the Digitalis Investigation Group (DIG) trial, digoxin reduced mortality or hospitalization due to heart failure (HF) in several pre-specified high-risk subgroups of HF patients, but data on protocol-specified 2-year outcomes were not presented. In the current study, we examined the effect of digoxin on HF death or...
Read the free full article.

Discover the European Journal of Heart Failure.

19 September - 21 September 2013 University Hospital, Inselspital, Bern, Switzerland

In this course, the most current evidence of the benefit of exercise training in heart failure patients, especially in the context of the long-term management, is summarized and presented with practical advice for assessment of exercise capacity and the application of exercise in different settings.